EydisBio, Inc.
Durham, United States (US) · Health and Medical
Do your work at EydisBio, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
Overview
EydisBio, Inc is a Durham, North Carolina-based biopharmaceutical company specializing in the development of highly selective protein kinase inhibitors.
We are dedicated to addressing significant unmet medical needs in autoimmune and inflammatory diseases, such as rheumatoid arthritis, chronic pain, and systemic sclerosis. Our core focus is on TAK1 inhibitors, a novel class of drugs designed to provide safer and more effective treatments by targeting inflammation at its source.
EydisBio’s proprietary inhibitors represent a significant advancement in therapeutic approaches, offering locally-acting, orally bioavailable solutions with the potential to overcome immune-induced therapy resistance. We are currently conducting in vivo efficacy and pilot safety studies, exploring applications beyond RA, including viral-induced ARDS and chronic pain management.
Founded by Dr. Timothy Haystead, a seasoned biotechnology leader with extensive experience in small molecule discovery, EydisBio is committed to translating innovative research into tangible benefits for patients.
We are dedicated to addressing significant unmet medical needs in autoimmune and inflammatory diseases, such as rheumatoid arthritis, chronic pain, and systemic sclerosis. Our core focus is on TAK1 inhibitors, a novel class of drugs designed to provide safer and more effective treatments by targeting inflammation at its source.
EydisBio’s proprietary inhibitors represent a significant advancement in therapeutic approaches, offering locally-acting, orally bioavailable solutions with the potential to overcome immune-induced therapy resistance. We are currently conducting in vivo efficacy and pilot safety studies, exploring applications beyond RA, including viral-induced ARDS and chronic pain management.
Founded by Dr. Timothy Haystead, a seasoned biotechnology leader with extensive experience in small molecule discovery, EydisBio is committed to translating innovative research into tangible benefits for patients.
Contact Details
info@eydisbio.com
Durham, United States (US), 201 West Main Street
Company Type
Private Limited Company
Employees
2-10
Categories
Keywords
You're invisible in searches for:
Add keywords that describe your company, services, or market to improve your visibility in search results.
Companies teams usually look at after EydisBio, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.